Stay updated with breaking news from Finished Dosage Forms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA assigns PDUFA target action date of March 8, 2024 New Drug Application supported by positive Phase III efficacy and safety clinical trial results Milestone builds upon Viatris' long-standing and...
Neuraxpharm rebrands Laboratorios Lesvi as Neuraxpharm Pharmaceuticals S.L.
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Mapi Pharma today announced that recent data from ongoing studies of GA Depot 40...
GA Depot is a Potential Long Acting Injection Solution for Multiple Sclerosis Patients Positive Results from Phase III GA Depot Study in Relapsing MS to...
DKSH Management Ltd. / Key word(s): Acquisition/Mergers & Acquisitions DKSH Performance Materials Strengthens its Life Sciences C...